TY - JOUR
T1 - Successful use of rituximab in granulomatosis with polyangiitis with aortic inflammation
AU - Pineda Bernal, Lucas
AU - Bitencourt, Nicole
AU - Batra, Kiran
AU - Solow, Elizabeth B
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Large-vessel inflammation, although rare, has been increasingly recognised as a complication of granulomatosis with polyangiitis (GPA) in recent years. The presentation is highly variable, ranging from an incidental finding to aortic dissection and rupture. Treatment has predominately consisted of a combination of cyclophosphamide and high dose corticosteroids with surgical intervention when indicated. We present the case of a 34-year-old male diagnosed with GPA after presenting with sinus and eye inflammation and the ensuing investigation revealed large vessel involvement that remarkably improved after 6 months of treatment with the combination of rituximab infusions, methotrexate and corticosteroids.
AB - Large-vessel inflammation, although rare, has been increasingly recognised as a complication of granulomatosis with polyangiitis (GPA) in recent years. The presentation is highly variable, ranging from an incidental finding to aortic dissection and rupture. Treatment has predominately consisted of a combination of cyclophosphamide and high dose corticosteroids with surgical intervention when indicated. We present the case of a 34-year-old male diagnosed with GPA after presenting with sinus and eye inflammation and the ensuing investigation revealed large vessel involvement that remarkably improved after 6 months of treatment with the combination of rituximab infusions, methotrexate and corticosteroids.
UR - http://www.scopus.com/inward/record.url?scp=85067208489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067208489&partnerID=8YFLogxK
M3 - Article
C2 - 30299239
AN - SCOPUS:85067208489
SN - 0392-856X
VL - 37
SP - 144
EP - 147
JO - Clinical and Experimental Rheumatology
JF - Clinical and Experimental Rheumatology
IS - 2
ER -